EUVIMEDEUVIMED entdecken
Crossref

Ultrahigh‐Efficacy VEGF Neutralization Using Carbonized Nanodonuts: Implications for Intraocular Anti‐Angiogenic Therapy

Hong-Jyuan Jian, Anisha Anand, Jui-Yang Lai iD, Chih-Ching Huang, David Hui-Kang Ma, Chi-Chun Lai, Huan-Tsung Chang

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202302881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Hong-Jyuan Jian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Chang Gung University, Taoyuan, 33302, Taiwan. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Tandem Mass Spectrometry. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital, Linkou, Chang Gung University, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular angiogenesis, associated with diseases such as retinopathy of prematurity and diabetic retinopathy, is a leading cause of irreversible vision loss. Herein, carbon nanodonuts (CNDs) with a donut‐shaped structure are synthesized using sodium alginate (SA) and 1,8‐diaminooctane (DAO) through a one‐step thermal process. The formation of SA/DAO‐CNDs occurs through a crosslinking reaction between SA and DAO, creating amide bonds followed by partial carbonization. In human retinal pigment epithelial cells exposed to H 2 O 2 or lipopolysaccharide, the SA/DAO‐CNDs display a more than fivefold reduction in reactive oxygen species and proinflammatory cytokines, such as IL‐6 and IL‐1β, when compared to carbonized nanomaterials produced exclusively from SA. Furthermore, the CNDs effectively inhibit vascular endothelial growth factor A‐165 (VEGF‐A 165 )‐induced cell migration and tube formation in human umbilical vein endothelial cells due to their strong affinity for VEGF‐A 165 , with a dissociation constant of 2.2 × 10 −14 M , over 1600 times stronger than the commercial drug bevacizumab (Avastin). Trypsin digestion coupled with LC‐MS/MS analysis reveals that VEGF‐A 165 interacts with SA/DAO‐CNDs through its heparin‐binding domain, leading to activity loss. The SA/DAO‐CNDs demonstrate excellent biocompatibility and potent anti‐angiogenic effects in chicken embryos and rabbit eyes. These findings suggest that SA/DAO‐CNDs hold promise as a therapeutic agent for treating various angiogenesis‐related ocular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor ATandem Mass SpectrometryAnimalsChick EmbryoHumansRabbitsChromatography, LiquidBevacizumabAngiogenesis InhibitorsHuman Umbilical Vein Endothelial Cells

Substanzen

Vascular Endothelial Growth Factor ABevacizumabAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Chang Gung University, Taoyuan, 33302, Taiwan.
  • Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, 33305, Taiwan.
  • Department of Materials Engineering, Ming Chi University of Technology, New Taipei City, 24301, Taiwan.
  • Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, 33303, Taiwan.
  • Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 20224, Taiwan.
  • Center of Excellence for the Oceans, National Taiwan Ocean University, Keelung, 20224, Taiwan.

ORCID-Profile: Jui-Yang Lai

Förderung

  • Chang Gung Memorial Hospital, Linkou
  • Chang Gung University
  • National Science and Technology Council

Zitieren

APA

Jian, H. J., Anand, A., Lai, J. Y., Huang, C. C., Ma, D. H., Lai, C. C., & Chang, H. T. (2024). Ultrahigh‐Efficacy VEGF Neutralization Using Carbonized Nanodonuts: Implications for Intraocular Anti‐Angiogenic Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302881

Vancouver

Jian HJ, Anand A, Lai JY, Huang CC, Ma DH, Lai CC, et al. Ultrahigh‐Efficacy VEGF Neutralization Using Carbonized Nanodonuts: Implications for Intraocular Anti‐Angiogenic Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302881

BibTeX
@article{Jian2024,
  author = {Jian, Hong-Jyuan and Anand, Anisha and Lai, Jui-Yang and Huang, Chih-Ching and Ma, David Hui-Kang and Lai, Chi-Chun and Chang, Huan-Tsung},
  title = {Ultrahigh‐Efficacy VEGF Neutralization Using Carbonized Nanodonuts: Implications for Intraocular Anti‐Angiogenic Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202302881}
}
Kostenlos starten →